Investigating the effects of iron supplementation on glucose metabolism during pregnancy
Official title: The Effect of Oral Iron Supplements on Hepcidin, Insulin and Glucose Metabolism in Pregnancy
Run by Swiss Federal Institute of Technology · NCT04008147 · Data updated 2026-11-12
This study is testing if taking iron supplements can help pregnant women with gestational diabetes and low iron levels manage their blood sugar better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Swiss Federal Institute of Technology Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | July 3, 2019 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 22, 2025 |
| Trial ID | NCT04008147 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women between 24-28 weeks gestation with a pre-pregnancy BMI under 27.5 and hemoglobin levels above 8.0 g/dl.
✕Probably not a fit
Patients with severe anemia, recent iron infusion, or other medical conditions affecting iron metabolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial examines the relationship between iron supplementation and glucose metabolism in pregnant women, specifically focusing on those with gestational diabetes and iron deficiency anemia. Participants will either refrain from taking iron supplements for 14 days or take a multivitamin containing iron while being monitored for changes in hepcidin levels and insulin sensitivity. The study aims to determine if high doses of oral iron can influence glucose metabolism and potentially impact pregnancy outcomes. The research is conducted at the Human Nutrition Laboratory ETH Zurich in collaboration with the University Hospital, Zürich.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for gestational diabetes and iron deficiency during pregnancy, enhancing maternal and fetal health.
How similar studies have gone: While the specific approach of this study may be novel, previous research has indicated a complex relationship between iron metabolism and glucose regulation during pregnancy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * week of pregnancy 24-28 * pre-pregnancy BMI \<27.5kg/m2 * singleton pregnancy * Hb \> 8.0 g/dl Willing to either: * not take any iron supplements for 14 days (however, participants will receive a similar amount of total iron during the 4 study days that they would normally receive over 14 days) OR * to take the multivitamin "Burgerstein Schwangerschaft and Stillzeit" supplements over the 14 days (contains 30 mg iron) Exclusion Criteria: * iron infusion within the past 6 months * severely anemic Hb\<8.0g/dl * acute or chronic disease * long-term medication * medical problems known to affect iron homeostasis * smoking
Where it's running
-
Human Nutrition Laboratory ETH Zurich
Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Nicole U Stoffel, PhD
- Email: nicole.stoffel@hest.ethz.ch
- Phone: +41 44 632 83 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How GLP-1 in the brain responds to sugar in people of different weights
This study tests whether the gut hormone GLP-1 changes how the brain reacts to sugar in people with healthy weight and those with obesity.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes
This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.